Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Hydrolases Products Line Has Been Updated By Scientists in Creative Enzymes

    Oct 20, 2016, 23:44 PM by Michael Croft
    SHIRLEY, NY - Oct 21, 2016 - October 20, 2016, experienced scientists in Creative Enzymes introduced a part of newly-updated products belonging to hydrolases products, which symbolized the beginning of developing hydrolases products in Creative Enzymes
    Full story
  • Illumina Builds Africa GWAS Chip With H3Africa Initiative

    Oct 20, 2016, 13:45 PM by Michael Croft
    Bio-IT World | Last week, Illumina announced that it is creating an array for genome-wide association studies (GWAS) by the Human Heredity and Health in Africa (H3Africa) Initiative. The array—which isn’t available yet—will be include 2.5 million variations of specific interest to African populations.
    Full story
  • How Spinal Decompression Stops The Pain, Strengthens The Back And Restores Functional Use

    Oct 20, 2016, 13:38 PM by Michael Croft
    WILMINGTON, NC, UNITED STATES - Oct 20, 2016 - As mentioned earlier in this report, the procedure provides relief of pain and symptoms associated with herniated discs, bulging or protruding intervertebral discs, degenerative disc disease, sciatica and chronic pain
    Full story
  • Perlara Signs Rare Disease Pact with Novartis

    Oct 20, 2016, 10:48 AM by Michael Croft
    Chemical & Engineering News | In a critical validation for a biotech firm espousing an unusual business model, Perlara has struck a deal to develop lysosomal storage disorder treatments with Novartis. The big pharma company will also make an undisclosed investment in the rare-disease-focused firm.
    Full story
  • News and Notes from ASHG 2016

    Oct 20, 2016, 10:30 AM by Michael Croft
    Bio-IT World News Brief | The American Society of Human Genetics annual meeting is currently underway in Vancouver, Canada. Here are some of the product news and company announcements released so far this week. Highlights include the Genome Aggregation Database, Illumina’s contribution to ClinVar, BabySeq news, and more.
    Full story
  • High diagnostic yields by Sapientia in 100,000 Genomes Project

    Oct 20, 2016, 10:09 AM by Michael Croft
    CAMBRIDGE, UNITED KINGDOM - Oct 20, 2016 - Congenica, a clinical interpretation partner for the UK 100,000 Genomes Project, has announced that its whole genome analysis platform Sapientia™ is detecting clinically relevant variants in over 35% of diagnostics reports returned to the NHS Genomic Medicine Centres (GMCs) for the Pilot and Main Phase studies
    Full story
  • Pine Biotech and Medexprim Selected as Grand Prize Winners in the 2016 Pistoia Alliance President’s Startup Challenge

    Oct 20, 2016, 09:32 AM by Michael Croft
    BOSTON, MA, USA - Oct 19, 2016 -  The Pistoia Alliance, a global, not for profit alliance that works to lower barriers to innovation in life sciences R&D, has today announced that Pine Biotech and Medexprim have been selected as the grand prize winners of its 2016 President’s Startup Challenge
    Full story
  • Elsevier's R&D Solutions Welcomes Four Biotech Start-Ups to the Hive

    Oct 20, 2016, 09:29 AM by Michael Croft
    NEW YORK, NY, UNITED KINGDOM - Oct 20, 2016 - Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that four start-up companies have been selected for The Hive, Elsevier's new incubator project for biotech and pharmaceutical start-up firms
    Full story
  • Spinal Decompression Therapy – Serving Wilmington, Leland & Hampstead NC

    Oct 19, 2016, 16:38 PM by Michael Croft
    WILMINGTON, NC, UNITED STATES - Oct 20, 2016 - Decompression relieves pressure that builds up on the discs and nerves. The task of relieving pain comes about as a result of drawing areas of herniated disc back into place
    Full story
  • Elsevier Launches New Release of Reaxys to Enable Chemists to Find the Shortest Path From Question to Answer

    Oct 19, 2016, 12:54 PM by Michael Croft
    NEW YORK, NY - Oct 19, 2016 - - Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of the new release of Reaxys, a chemistry research experience that delivers relevant literature and data more than twice as fast as any other solution
    Full story
  • Elsevier Opens Second Reaxys ChemSearch Challenge, Inviting Entrants to Compete in Solving Chemistry Conundrums

    Oct 19, 2016, 12:49 PM by Michael Croft
    NEW YORK, NY - Oct 19, 2016 - Elsevier, a world-leading provider of scientific, technical and medical information products and services, has today announced that the 2016 Reaxys ChemSearch Challenge is now live, following its successful debut last year
    Full story
  • Discovery of Carbon Storage Signaling Mechanism in Algae Offers New Potential for Sustainable Biofuel Production

    Oct 19, 2016, 09:52 AM by Michael Croft
    ST. LOUIS, MO, UNITED STATES - Oct 19, 2016 - James Umen, Ph.D., associate member at Donald Danforth Plant Science Center, and colleagues have discovered a way to make algae better oil producers without sacrificing growth
    Full story
  • The Cure for Cancer Is Data—Mountains of Data

    Oct 19, 2016, 09:38 AM by Michael Croft
    WIRED | We must access genetic info from millions of cancer patients to make the connections necessary to battle the disease. It won't be easy, but Eric Schadt believes we can do it.
    Full story
  • CRISPR Therapeutics’ IPO Falls Short Of Target

    Oct 19, 2016, 09:18 AM by Michael Croft
    The Boston Globe | The gene-editing technology company with Cambridge operations sold 4 million share at $14 each. It had planned to sell 4.7 million shares at $15 to $17 apiece.
    Full story
  • Certara’s Simcyp Division Awarded Modeling and Simulation Grant from the US FDA’s Office of Generic Drugs

    Oct 19, 2016, 08:24 AM by Michael Croft
    PRINCETON, NJ - Oct 19, 2016 - Certara®, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced that the Office of Generic Drugs (OGD), US Food and Drug Administration (FDA) has awarded it a multi-year research grant to create and validate a physiologically-based pharmacokinetic (PBPK) modeling and simulation framework that complements existing models within the Simcyp® Population-based Simulator
    Full story
  • Oxford Genetics Opens New Facility to Support R&D in Cell and Gene Therapy

    Oct 19, 2016, 06:59 AM by Michael Croft
    OXFORDSHIRE, UK - Oct 19, 2016 - Oxford Genetics Ltd, a leading biotech which specialises in DNA design, protein expression optimization and cell line development technologies and services, has moved its operations to new state-of-the-art laboratories at The Oxford Science Park
    Full story
  • Centre of Molecular Medicine at Karolinska Institute to extend research partnership with BC Platforms

    Oct 19, 2016, 03:17 AM by Michael Croft
    BASEL, SWITZERLAND - Oct 19, 2016 - BC Platforms, a world leader in genomic data management solutions, today announced that the Center for Molecular Medicine (CMM) at the Karolinska Institute has extended its research partnership with BC Platforms to encompass its newest version of the platform and include its BC|GENOME and BC|TILING tools to add capacity for large scale next generation sequencing as well as superior data handling and analytics
    Full story
  • Creative BioMart Added Resource Column on Its Official Website

    Oct 19, 2016, 02:17 AM by Michael Croft
    SHIRLEY, NY - Oct 19, 2016 - Creative BioMart, a world leading biotech company committed to providing advanced tools for life sciences studies, is pleased to updated its official website recently
    Full story
  • DNAstack Launched for Google Cloud Genomics

    Oct 18, 2016, 16:55 PM by Michael Croft
    Bio-IT World | This week DNAstack, a Toronto-based genomic software company, launched its Google Cloud platform to accelerate genetic disease research and precision medicine built on GA4GH APIs.
    Full story
  • Cenduit to Showcase Industry Solutions and Expertise at IRT 2016

    Oct 18, 2016, 11:04 AM by Michael Croft
    RESEARCH TRIANGLE PARK, NC, UNITED STATES - Oct 18, 2016 - Cenduit, a joint venture between QuintilesIMS and Thermo Fisher Scientific, is showcasing its solutions and expertise as the largest interactive response technology (IRT) specialist in the world at IRT 2016 — Interactive Response Technologies in Clinical Trials, October 25-26, 2016 in Philadelphia
    Full story
  • «
  • 331 (current)
  • 332
  • 333
  • 334
  • 335
  • 336
  • 337
  • 338
  • 339
  • 340
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy